phase readout
saveNCT04936308: Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Arthritis, Psoriatic
view source ↗
comments(0)
5-min edit window · permanent after that